Stay updated on Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial
Sign up to get notified when there's something new on the Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial page.

Latest updates to the Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial page
- Check2 days agoChange DetectedThe page has updated its version number from v2.16.4 to v2.16.5 and removed specific future dates related to the ClinicalTrials.gov data ingest modernization.SummaryDifference0.8%
- Check9 days agoChange DetectedThe page now lists 238 locations for the study, down from 239, and includes updated dates for the study timeline.SummaryDifference0.4%
- Check16 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025, and the revision number has changed from v2.16.2 to v2.16.4.SummaryDifference0.4%
- Check23 days agoChange DetectedThe study's recruitment status has changed to 'Not yet recruiting', and the number of locations has been updated to 239. Additionally, the contact information for the study has been revised.SummaryDifference15%
- Check31 days agoChange DetectedThe web page has been updated to reflect the latest version of the clinical trial for elranatamab, including new details about the study's purpose, participant criteria, and treatment arms, with a new revision date of 2025-05-31.SummaryDifference11%
- Check38 days agoChange DetectedThe web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference0.8%
Stay in the know with updates to Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial page.